Clinical Trials

Biomechanical studies:

Stronger fixation, rotationally stable

X-Bolt superior and more forgiving in static and cyclic testing.

 

Clinical studies:

WHiTE One : RCT in (high-risk) unstable A2 and A3 fractures

Dementia patients able to be included (unlike most in literature)

0% cut-out for X-Bolt, 6% for SHS screw

Better 4-week EQ5D scores for X-Bolt

 

 

WHiTE Four: largest ever hip fracture fixation RCT

0.8% cut-out rate for X-Bolt (lowest-ever cut-out rate in any large hip# RCT)

 

Data issues with WHiTE Four include 11% crossovers (randomized to XHS but received SHS), 5% 'treatment unknown', Baseline frailty not adjusted for, Missing reoperation data for SHS cohort